首页 | 本学科首页   官方微博 | 高级检索  
     

大黄素对肺炎链球菌肺炎大鼠氧化应激损伤及miR-34a/SIRT1轴的影响
引用本文:张小红,王红民,李杨,胡朝阳,李凤芝,常瑞,黄晗,靳莉. 大黄素对肺炎链球菌肺炎大鼠氧化应激损伤及miR-34a/SIRT1轴的影响[J]. 天津医药, 2021, 49(6): 588-592. DOI: 10.11958/20203007
作者姓名:张小红  王红民  李杨  胡朝阳  李凤芝  常瑞  黄晗  靳莉
作者单位:1郑州大学附属郑州中心医院呼吸与危重症医学科(邮编450000);2郑州大学第一附属医院呼吸科
基金项目:2018年度河南省科技攻关项目
摘    要:目的探究大黄素对肺炎链球菌肺炎大鼠氧化应激损伤及微小RNA-34a/沉默信息调节因子2相关酶1(miR-34a/SIRT1)轴的影响。方法 60只雄性SD大鼠按照随机数字表法分为假手术组、模型组、低剂量(20 mg/kg)、中剂量(40 mg/kg)和高剂量(80 mg/kg)大黄素组,每组12只。采用气管滴加肺炎链球菌法制备肺炎模型,建模成功后24 h,大黄素干预组分别腹腔注射大黄素溶液,每天1次,连续7 d。HE染色观察肺组织病理变化,酶联免疫吸附测定(ELISA)法检测肺组织肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)和谷胱甘肽过氧化物酶(GSH-Px)水平,可见分光光度法检测超氧化物歧化酶(SOD)、丙二醛(MDA)水平,q PCR检测肺组织miR-34a、SIRT1 mRNA水平,Western blot检测肺组织SIRT1蛋白表达。结果假手术组大鼠肺组织正常,无明显病理改变;模型组大鼠肺泡塌陷,有大量炎性细胞浸润;低、中、高剂量大黄素组肺组织炎性病变均减轻。与假手术组比较,模型组肺组织TNF-α、IL-6、MDA、miR-34a水平显著增加(P<0.05...

关 键 词:大黄素  肺炎,肺炎球菌性  大鼠,Sprague-Dawley  氧化性应激  微小RNA-34a/沉默信息调节因子2相关酶1轴
收稿时间:2020-11-02
修稿时间:2021-02-02

Effects of emodin on oxidative stress damage and miR-34a/SIRT1 axis in rat model of streptococcus pneumoniae pneumonia
ZHANG Xiao-hong,WANG Hong-min,LI Yang,HU Chao-yang,LI Feng-zhi,CHANG Rui,HUANG Han,JIN Li. Effects of emodin on oxidative stress damage and miR-34a/SIRT1 axis in rat model of streptococcus pneumoniae pneumonia[J]. Tianjin Medical Journal, 2021, 49(6): 588-592. DOI: 10.11958/20203007
Authors:ZHANG Xiao-hong  WANG Hong-min  LI Yang  HU Chao-yang  LI Feng-zhi  CHANG Rui  HUANG Han  JIN Li
Affiliation:1 Department of Respiratory and Critical Care Medicine, Zhengzhou Central Hospital Affiliated to Zhengzhou University,
Zhengzhou 450000, China; 2 Department of Respiratory Medicine, the First Affiliated Hospital of Zhengzhou University
Abstract:Objective To investigate the effects of emodin on oxidative stress injury and microRNA-34a/silentinformation regulator factor 2 related enzyme 1 (miR-34a/SIRT1) axis in streptococcus pneumoniae pneumonia rat model. Methods According to random number table, sixty rats were divided into sham operation group, model group, low-dose (20mg/kg) emodin group, middle-dose (40 mg/kg) emodin group and high-dose (80 mg/kg) emodin group, with 12 rats in eachgroup. The model of pneumonia was established by intratracheal instillation of streptococcus pneumoniae. At 24 h aftersuccessful modeling, the emodin intervention group was intraperitoneally injected with emodin solution once a day for 7 days.HE staining was used to detect the pathological changes of lung tissue. Enzyme-linked immunosorbent assay (ELISA) wasused to detect the levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and glutathione peroxidase (GSH-Px).UV-VIS spectrophotometer was used to detect the levels of superoxide dismutase (SOD) and malondialdehyde (MDA). Thelevels of miR-34a and SIRT1 mRNA in lung tissue were detected by qPCR. The expression of SIRT1 protein was detectedby Western blot assay. Results In the sham operation group, the lung tissue was normal without obvious pathologicalchanges. In the model group, it was found that the alveoli collapsed and a large number of inflammatory cells infiltrated. Inthe low, middle and high dose emodin groups, the inflammatory lesions of lung tissue were alleviated. Compared with those inthe sham operation group, the levels of TNF-α, IL-6, MDA and miR-34a were significantly higher in the model group (P <0.05), and the levels of SOD, GSH-Px and SIRT1 mRNA and protein in lung tissue were significantly lower (P < 0.05).Compared with those in the model group, the levels of TNF- α, IL-6, MDA and miR-34a were significantly lower in themiddle and high-dose emodin groups (P < 0.05), and the levels of SOD, GSH-Px and SIRT1 mRNA and protein in lungtissue were significantly higher (P < 0.05), in which the high-dose emodin group showed the most obvious changes. Conclusion Emodin can reduce inflammatory reaction and oxidative stress injury in rat model of streptococcuspneumoniae pneumonia, which may be related to the regulation of miR-34a/SIRT1 axis.
Keywords:emodin  pneumonia   pneumococcal   rats   Sprague-Dawley   oxidative stress  microRNA-34a/silentinformation regulator factor 2 related enzyme 1 axis  
点击此处可从《天津医药》浏览原始摘要信息
点击此处可从《天津医药》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号